Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Maher

Showing results (31-40 of 171) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|October 17, 1987
Aortic and mitral valve calcification in patients with end-stage renal diseaseE R Maher, G Young, B Smyth-Walsh, et al.
Molecular Pathology : MP|July 31, 2001
Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancerA J Alvi, J S Rader, M Broggini, et al.
Eye (London, England)|January 1, 1991
Ophthalmological screening for von Hippel-Lindau diseaseA T Moore, E R Maher, P Rosen, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 23, 2013
How does altering the resolution of chromosomal microarray analysis in the prenatal setting affect the rates of pathological and uncertain findings?S C Hillman, D J McMullan, L Silcock, et al.
Journal of Medical Genetics|August 3, 2005
Alternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndromeN Diaz-Meyer, Y Yang, S N Sait, et al.
Journal of Medical Genetics|May 12, 2000
Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genesE R Woodward, S C Clifford, D Astuti, et al.
Journal of Medical Genetics|March 1, 1993
Age at onset in Huntington's disease and methylation at D4S95W Reik, E R Maher, P J Morrison, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxineS H Morgan, E R Maher, P Purkiss, et al.
British Journal of Cancer|July 4, 1998
Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genesS C Clifford, K Czapla, F M Richards, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 14, 2012
Microarray comparative genomic hybridization in prenatal diagnosis: a reviewS C Hillman, D J McMullan, D Williams, et al.
Pageof 18

Showing results (31-40 of 171) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|October 17, 1987
Aortic and mitral valve calcification in patients with end-stage renal diseaseE R Maher, G Young, B Smyth-Walsh, et al.
Molecular Pathology : MP|July 31, 2001
Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancerA J Alvi, J S Rader, M Broggini, et al.
Eye (London, England)|January 1, 1991
Ophthalmological screening for von Hippel-Lindau diseaseA T Moore, E R Maher, P Rosen, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|July 23, 2013
How does altering the resolution of chromosomal microarray analysis in the prenatal setting affect the rates of pathological and uncertain findings?S C Hillman, D J McMullan, L Silcock, et al.
Journal of Medical Genetics|August 3, 2005
Alternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndromeN Diaz-Meyer, Y Yang, S N Sait, et al.
Journal of Medical Genetics|May 12, 2000
Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genesE R Woodward, S C Clifford, D Astuti, et al.
Journal of Medical Genetics|March 1, 1993
Age at onset in Huntington's disease and methylation at D4S95W Reik, E R Maher, P J Morrison, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988
Oxalate metabolism in end-stage renal disease: the effect of ascorbic acid and pyridoxineS H Morgan, E R Maher, P Purkiss, et al.
British Journal of Cancer|July 4, 1998
Hepatocyte growth factor-stimulated renal tubular mitogenesis: effects on expression of c-myc, c-fos, c-met, VEGF and the VHL tumour-suppressor and related genesS C Clifford, K Czapla, F M Richards, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 14, 2012
Microarray comparative genomic hybridization in prenatal diagnosis: a reviewS C Hillman, D J McMullan, D Williams, et al.
Pageof 18